CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CardiNor is developing a new blood test to measure Secretoneurin levels, a biomarker that helps identify patients at risk for life-threatening arrhythmias. This diagnostic tool aims to improve patient stratification and reduce unnecessary implantable cardioverter-defibrillator surgeries.
Cardiovascular disease (CVD) is the no. 1 killer worldwide.
At least half of CVD deaths is caused by ventricular arrhythmias that lead to sudden cardiac death (SCD).
The diagnosis of arrhythmias is difficult but crucial for accurate decision-making and patient survival, being more frequent and carrying greater risk in heart failure (HF) patients.
When managing HF patients, cardiologists currently prescribe an ECG (which may detect an arrhythmia) and an echocardiogram to measure the blood ejectio…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
